ScholarIQanswers from OpenAlex & ORCID
M. Angelyn Bethel
ResearcherPublications, citations & collaboration network
M. Angelyn Bethel is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does M. Angelyn Bethel have?
ScholarIQindexed works
M. Angelyn Bethel has 132 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does M. Angelyn Bethel have?
ScholarIQcitation count
M. Angelyn Bethel has 19,916 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of M. Angelyn Bethel?
ScholarIQh-index
M. Angelyn Bethel has an h-index of 40 in OpenAlex.
What is the i10-index of M. Angelyn Bethel?
ScholarIQi10-index
M. Angelyn Bethel has an i10-index of 76 in OpenAlex.
What is the ORCID of M. Angelyn Bethel?
ScholarIQorcid
The ORCID for M. Angelyn Bethel is on the source record.
What is the OpenAlex record for M. Angelyn Bethel?
ScholarIQopenalex
The OpenAlex for M. Angelyn Bethel is on the source record.
What are the most-cited papers on M. Angelyn Bethel?
ScholarIQmost cited works
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, David R. Matthews, H. A. W. Neil
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong, John B. Buse, Samuel S. Engel, Jyotsna Garg, Robert Josse, Keith D. Kaufman, Joerg Koglin, Scott Korn, John M. Lachin, Darren K. McGuire, Michael Pencina, Eberhard Standl, Peter P. Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D. Peterson, Rury R. Holman
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman, M. Angelyn Bethel, Robert J. Mentz, Vivian P. Thompson, Yuliya Lokhnygina, John B. Buse, Juliana C.N. Chan, Jasmine Choi, Stephanie M. Gustavson, Nayyar Iqbal, Aldo P. Maggioni, Steven P. Marso, Peter Öhman, Neha J. Pagidipati, Neil R Poulter, Ambady Ramachandran, Bernard Zinman, Adrian F. Hernandez
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
M. Angelyn Bethel, Rishi Patel, Peter Merrill, Yuliya Lokhnygina, John B. Buse, Robert J. Mentz, Neha J. Pagidipati, Juliana C.N. Chan, Stephanie M. Gustavson, Nayyar Iqbal, Aldo P. Maggioni, Peter Öhman, Neil R Poulter, Ambady Ramachandran, Bernard Zinman, Adrian F. Hernandez, Rury R. Holman
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan, Jean‐Louis Chiasson, Huimei Feng, Junbo Ge, Hertzel C. Gerstein, Richard Gray, Yong Huo, Zhihui Lang, John J.V. McMurray, Lars Rydén, Stefan Schröder, Yihong Sun, Michael J. Theodorakis, Michał Tendera, Lynne Tucker, Jaakko Tuomilehto, Yidong Wei, Wenying Yang, Duolao Wang, Dayi Hu, Changyu Pan, Joanne F. Keenan, Joanne Milton, Zoë Doran, Chris Bray, Jean L. Rouleau, Jane Collier, Stuart Pocock, Eberhard Standl, Karl Swedberg, Jianping Weng, Dong Zhao, Mark C. Petrie, Eugene Connolly, Pardeep S. Jhund, Michael R. MacDonald, Rachel C. Myles, Rong Bai, Jing Li, Zhaoping Liu, Zhenyu Liu, Dantao Peng, Tong Qiguang, Chunxue Wang, Xiaowei Yan, Yuqing Zhang, Jingmin Zhou, Naveed Sattar, Miles Fisher, John R. Petrie, M. Angelyn Bethel, Wen Xu, Sarah Hearn, Anurag Kappai, Shu-Yi Su, Winitha Liyanage, Sanjoy K. Paul, Emanuela Pozzi, Arne Ring, Rajbir Athwal, Priyanka Batra, Andrea Ferch, Natasha Groves, Irene Kennedy, Olga Nawalaniec, Yash Patel, Rachel Roberts, Victoria Rush, Jayne Starrett, Jennifer Tang, Jing Bi, Zhe Jiang, Hua Wei, Xiaoshuai Wei, Xuan Zhang, Jun Yin, Yu Sun, Rong Hu, Yang Liu, Jianjing Long, Yuefeng Long, Guofang Qiao, Haoyi Qiao, Xiaochun Sun, Yucheng Zhang, Jing Zhou, Bangning Wang, Bin Chen, Lili Deng, Xiaoning Han, Taohong Hu, Qi Hua, Yanming Huo, Hongmei Li, Hongwei Li, Lihua Liu, Juming Lu, Changsheng Ma